Galzin Capsule, Gelatin Coated
Product Images NDC 71863-124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Galzin (NDC 71863-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eton Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Apace Bottle Label (25 mg Bottle Apace Label)

25 mg Apace Bottle Label (25 mg Bottle Apace Label)
This text describes 25mg zinc acetate capsules in aqua blue color. Each capsule contains Zinc Acetate equivalent to 25mg zinc. It provides instructions for storage at 25°C with excursions permitted between 15-30°C. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. Additionally, it mentions to keep the medication out of the reach of children.*
FDA Label Image

50 mg Galzin Bottle Label (50 mg Bottle Apace Label)

50 mg Galzin Bottle Label (50 mg Bottle Apace Label)
This text provides information on a medication in capsule form, specifically "GALZ'N" containing zinc acetate. Each orange capsule contains 50 mg of zinc acetate. The usual dosage and storage instructions are mentioned. The medication should be kept in a tight, light-resistant container at room temperature. The text also includes the NDC code, the prescription, and the quantity of capsules in the packaging.*
FDA Label Image

Galzin Structural Formula (Galzin Structural Formula)

Galzin Structural Formula (Galzin  Structural Formula)
This text provides information about a chemical compound with a molecular weight of 219.51. The compound seems to contain elements such as Carbon, Hydrogen, and Oxygen. The specific structure or name of the compound is not clearly mentioned in the text.*
FDA Label Image

Clinical Trials Table (Galzin Clinical Trials Table)

Clinical Trials Table (Galzin Clinical Trials Table)
This information appears to be related to the dosing and copper balance of various patients in a study, based on different zinc doses administered. The table shows the number of patients studied, the specific dose regimens, mean copper balance, and total doses. This data can be used to analyze the effects of different zinc doses on the copper balance of patients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.